je.st
news
Tag: clinical trial
AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients
2014-05-08 15:00:00| Merck.com - Research & Development News
Dateline City: WUPPERTAL, Germany & WHITEHOUSE STATION, N.J. WUPPERTAL, Germany & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--AiCuris and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent for the prevention of human cytomegalovirus (CMV) infection in patients receiving bone marrow transplant. Language: English Contact: MerckMedia:Caroline Lappetito, 267-305-7639orInvestors:Carol Ferguson, 908-423-4465orAiCurisMedia:Katja Woestenhemke, +49-202-317-63-1176 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
publication
journal
agent
Get Clinical Trial Advice, FDA Insights and Formulating Expertise
2014-04-29 17:00:00| Happi Breaking News
All that and an exhibition, too, at Happi's Anti-Aging Conference & Tabletop 2014.
Tags: advice
trial
clinical
expertise
BIO Releases Principles on Clinical Trial Data Sharing
2014-03-25 05:00:00| Industrial Newsroom - All News for Today
By releasing Principles on Clinical Trial Data Sharing, adopted by its Health Section Governing Board, BIO reaffirmed and broadened its commitment to improving human health through development of innovative therapies. BIO President and CEO Jim Greenwood cited how "responsible clinical trial data sharing advances public health and scientific discourse, honors research participants’ expectations of privacy through informed consent, and promotes biomedical innovation." This story is related to the following:Trade Associations
Tags: data
trial
releases
sharing
Risk-Based Monitoring for Clinical Trial Sites Keys to Successful Implementation
2014-03-24 12:40:55| drugdiscoveryonline News Articles
Date: Thursday, May 1, 2014 Time: 1pm - 2:30pm EST Duration: 90 Minutes - Online Price: $299 - Introductory Rate
Tags: sites
trial
successful
monitoring
Temperature-Controlled Shippers protect clinical trial shipments.
2014-03-18 13:31:07| Industrial Newsroom - All News for Today
Available in 4 payload sizes from 3–11.5 L, ThermoSafe Via Series maintain pharmaceuticals, biologics, vaccines, and other products at refrigerated, controlled room temperature (CRT), or frozen temperatures for 1–5 days, depending on configuration, during transport. Modular design lets end-users convert these pre-qualified shippers from reusable system to one-way configuration, and zero refrigerant bench time conserves time during product loading. This story is related to the following:Temperature Controlled Packaging |
Tags: trial
protect
clinical
shipments